Chase AIPricingFAQs
Display currency
Loading news…

Nexien BioPharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Denver, Colorado, United States Founded 2017 1-10 employees For Profit

Nexien BioPharma develops cannabinoid based medications for specific medical conditions and disorders.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
1
Monthly Visits
Available in Pro
Contacts
1

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
IT spend
$3K

Company Info

Founded
2017
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
4
HQ
Denver, Colorado, United States
Region
Greater Denver Area, Western US

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.6
Trend (90d)
-0.1

Acquisitions by Nexien BioPharma

Loading columns…
0 of 0Show
Page 1 / 1

Key People at Nexien BioPharma

Founder, CEO, EVP & Chairman Of The Board
1
professional contacts at Nexien BioPharma
Contact execs at Nexien BioPharma

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Nexien BioPharma

Loading news…

FAQs about Nexien BioPharma

People who checked this page also checked these

Sectors Nexien BioPharma invests & acquires in

M&A by year

Browse the full Acquirezy directory.
Nexien BioPharma - Company Profile, Full Acquisitions List, Funding and Investments